GlaxoSmithKline
GSK
$38.19
Share price
0.03%
Change (1 day)
-1.34%
Change (1 year)
Categories
GlaxoSmithKline (GSK) - Net assets
Net assets on the balance sheet as of March 2025 : $17.64 Billion USD
According to GlaxoSmithKline's latest financial reports the company has $17.64 Billion USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
GlaxoSmithKline - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $$16.42 B | 0.74% |
| 2023-12-31 | $$16.30 B | 33.46% |
| 2022-12-31 | $$12.21 B | -57.6% |
| 2021-12-31 | $$28.80 B | 1.57% |
| 2020-12-31 | $$28.36 B | 17.83% |
| 2019-12-31 | $$24.07 B | 416.44% |
| 2018-12-31 | $$4.66 B | -1.15% |
| 2017-12-31 | $$4.71 B | -23% |
| 2016-12-31 | $$6.12 B | -53.45% |
| 2015-12-31 | $$13.15 B | 71.2% |
| 2014-12-31 | $$7.68 B | -40.36% |
| 2013-12-31 | $$12.88 B | 18.34% |
| 2012-12-31 | $$10.88 B | -20.63% |
| 2011-12-31 | $$13.71 B | -8.8% |
| 2010-12-31 | $$15.04 B | -13.46% |
| 2009-12-31 | $$17.38 B | 42.59% |
| 2008-12-31 | $$12.19 B | -38.13% |
| 2007-12-31 | $$19.70 B | 4.31% |
| 2006-12-31 | $$18.89 B | 44.75% |
| 2005-12-31 | $$13.05 B | 10.58% |
| 2004-12-31 | $$11.80 B | -21.96% |
| 2003-12-31 | $$15.12 B | 27.67% |
| 2002-12-31 | $$11.84 B | -2.7% |
| 2001-12-31 | $$12.17 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 AstraZeneca AZN | $41.13 B | 133.14% | 🇬🇧 UK |
 Pfizer PFE | $90.63 B | 413.75% | 🇺🇸 USA |
 Merck MRK | $48.40 B | 174.34% | 🇺🇸 USA |
 Novartis NVS | $38.45 B | 117.95% | 🇨🇭 Switzerland |
 Sanofi SNY | $80.51 B | 356.36% | 🇫🇷 France |
 Teva Pharmaceutical Industries TEVA | $6.26 B | -64.47% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $0.53 B | -96.99% | 🇺🇸 USA |